tiprankstipranks
Halozyme price target lowered to $57 from $62 at Wells Fargo
The Fly

Halozyme price target lowered to $57 from $62 at Wells Fargo

Wells Fargo lowered the firm’s price target on Halozyme (HALO) to $57 from $62 and keeps an Equal Weight rating on the shares. The firm said on Friday that it is updating its model for new Halozyme guidance but continues to see terminal growth issues due to lack of new deals. Wells sees near-term upside, but royalty step down post ENHANZE patent expiry keeps it on the sidelines.

Stay Ahead of the Market:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles